Launch

Ketchum Launches Vital Health, Helping Healthcare Brands Become Healthier Themselves

July 17, 2018

NEW YORK, July 17, 2018 – Leading global communications consultancy Ketchum today unveiled its Vital Health suite of services, designed to help companies in the health sector find the root causes of their complex challenges and then imagine bold communications solutions that provide the best of health and business outcomes at the same time. The […]

Wasdell Group launch serialisation service

July 12, 2018

The Wasdell Group (Wasdell), a leading outsourcing partner to companies within the pharmaceutical, medical device and clinical trials industries, has launched its serialisation service ahead of the EU FMD and US DSCSA implementation deadlines. Following a £2.8 million investment into serialisation capabilities in 2016, the company will offer compliant products to all markets, including Europe […]

Novartis launches the Galaxies of Hope app, a digital experience for the Neuroendocrine Tumor (NET) cancer community

July 12, 2018

EAST HANOVER, N.J., July 12, 2018 /PRNewswire/ — Novartis today launched its Galaxies of Hope app, a unique digital experience created to support the neuroendocrine tumor (NET) community. Galaxies of Hope engages users through the art of visual storytelling, using the actual words and voices of patients, caregivers, and physicians who are part of the NET cancer community. […]

Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon® Patch

July 9, 2018

HERTFORDSHIRE, England and PITTSBURGH, July 9, 2018 /PRNewswire/ — Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Rivastigmine Transdermal System, 4.6 mg/24 hrs, 9.5 mg/24 hrs and 13.3 mg/24 hrs, a generic version of Novartis’ Exelon® Patch. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, […]

Quorum Review IRB Launches Live IRB Interface for Veeva Vault eTMF

June 21, 2018

(SEATTLE, WA): Quorum Review IRB, the most preferred central IRB, today announced a live data sharing interface for Veeva Vault eTMF, a cloud application that enables all TMF processes and documents to be managed in one system, in real time, as they are executed. The first customers are now using an IRB interface with Veeva […]

Dr. Reddy’s Laboratories Announces the Launch of Levetiracetam in Sodium Chloride Injection in the U.S. Market

June 19, 2018

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Levetiracetam in Sodium Chloride Injection, 500 mg/100 mL (5 mg/mL), 1,000 mg/100 mL (10 mg/mL), and 1,500 mg/100 mL (15 mg/mL) single-dose infusion bags, a therapeutic equivalent generic version of HQ Specialty Pharma Corporation’s […]

Saama Launches Deep Learning Intelligent Assistant (DaLIA) to Solve Clinical Development Pain Points

June 11, 2018

Saama Launches Deep Learning Intelligent Assistant (DaLIA) to Solve Clinical Development Pain Points AI-Informed Virtual Assistant Elevates Functionality of Existing Clinical Trial Solutions CAMPBELL, CA – (June 11, 2018) – Saama Technologies, Inc., a leading data analytics company, today announced the launch of a unique set of Artificial Intelligence (AI) capabilities specifically designed to alleviate […]

Amerigen Launches Generic Bexarotene Capsules

June 8, 2018

LYNDHURST, N.J., June 7, 2018 /PRNewswire/ — Amerigen Pharmaceuticals Limited (“Amerigen”) today announced the commercial launch of its generic bexarotene 75mg capsules following the recent approval of the Company’s corresponding Abbreviated New Drug Application (“ANDA”) by the U.S. Food and Drug Administration. Amerigen’s bexarotene product is a generic equivalent to Valeant Pharmaceuticals’ Targretin® Capsules. Amerigen’s […]

New Company Hu-manity.co Uses Blockchain to Declare a 31st Human Right, Empowering All Humans to Claim Legal Ownership of Inherent Human Data

June 7, 2018

PRINCETON, N.J.–(BUSINESS WIRE)–Hu-manity.co, a new company designed to create decentralized human rights using proprietary technology and legal innovations on blockchains, has declared the 31st human right: “Everyone has the right to legal ownership of their inherent human data as property.” #31 is the first decentralized human right, and an addition to the existing 30 rights […]

Innovus Pharma Announces the Launch of Its Product AllerVarx™ in Canada for Allergic Rhinitis

June 6, 2018

SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced the launch of its product AllerVarx™, which is a clinically proven, Natural Health […]

Certara Launches Version 8.1 of its Industry-leading Phoenix PK/PD Modeling and Simulation Software; Introduces Professional Certification Program

June 5, 2018

Certara provides scientists with automated, comprehensive tools for PK/PD analysis and modeling, and announces industry’s first PK/PD certification program for Phoenix software in partnership with Credly Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced the launch of Phoenix® 8.1. Phoenix is the most advanced and […]

Rigel Announces Availability of TAVALISSE™ (fostamatinib disodium hexahydrate) in the U.S. Launches RIGEL ONECARE™ to Support Patients and Providers

May 29, 2018

SOUTH SAN FRANCISCO, Calif., May 29, 2018 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced that TAVALISSE™ (fostamatinib disodium hexahydrate) is available by prescription for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. TAVALISSE, an oral spleen tyrosine kinase (SYK) […]

New control concepts for the pharma shop floor: Werum IT Solutions and Nymi enter partnership

May 29, 2018

New control concepts for the pharma shop floor: Werum IT Solutions and Nymi enter partnership Development of authentication solutions for pharmaceutical and biotech production / Increasing data integrity and efficiency / Nymi Band provides secure operator authentication Lüneburg, Germany, 29 May 2018 – Werum IT Solutions, the world’s leading supplier of manufacturing execution systems (MES) […]

Innovus Pharma Announces the Launch of its Product Vesele® in Canada

May 23, 2018

SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced the launch of its product Vesele®, approved by Health Canada for the increase […]

Certara’s Analytica Laser Launches Market Access Radar Providing Biopharma and Medical Device Companies with Breaking News on Access to Health Technologies Globally

May 22, 2018

Analytica Laser’s population health intelligence experts monitor, compile and deliver relevant and up-to-the minute global market access news via newsletter and web portal Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced the launch of Analytica Laser’s Market Access Radar™, a three times weekly market access […]

Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Saudi Arabia by Hikma Pharmaceuticals LLC

May 15, 2018

Basel, Switzerland, May 15, 2018 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its partner Hikma Pharmaceuticals LLC has launched Basilea’s hospital antibiotic Zevtera® (ceftobiprole) in Saudi Arabia. Adesh Kaul, Chief Corporate Development Officer, said: “We are very pleased with the launch of Zevtera in Saudi Arabia. This is the first launch by our […]

Pharmascience Inc. Launches (Pr)pms-NITROFURANTOIN, First Generic Bioequivalent to MacroBID® Available on the Market, for the Treatment of Urinary Tract Infections

May 14, 2018

MONTREAL, May 14, 2018 /CNW/ – Today, Pharmascience Inc. launches Prpms-NITROFURANTOIN (nitrofurantoin monohydrate / macrocrystals capsules) in Canada for the treatment of urinary tract infections.   “With the launch of Prpms-NITROFURANTOIN, manufactured in Canada, we become the first generic bioequivalent to MacroBID® on the Canadian market,” said Jean-Guy Goulet, Chief Operating Officer at Pharmascience Inc. […]

Oxford Genetics Announces New Online Customer Portal for Custom Research Services

May 14, 2018

Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, today announced the launch of a new online customer portal designed to enable customers to better monitor project progress and track communications. This new portal provides customers with real-time updates through 24/7 access to the status of the projects they […]

Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease

May 11, 2018

TORONTO, May 10, 2018 /CNW/ – Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced the launch of Teva-Cyclosporine® ophthalmic emulsion, 0.05% w/v, a Health Canada approved twice-daily eye drop solution and the first generic version of Restasis® (cyclosporine) in Canada.   Cyclosporine ophthalmic emulsion is indicated for the treatment of moderate to […]

Searchlight Pharma Announces Launch of Bulkamid® for Treatment of Female Stress Urinary Incontinence

May 10, 2018

MONTREAL, May 10, 2018 /CNW Telbec/ – Searchlight Pharma, a Canadian specialty pharmaceutical company committed to improving life-long human health and wellness, today announced the launch of commercial activities for Bulkamid® for the treatment of female stress urinary incontinence (“SUI”). Bulkamid® which is manufactured by Contura International, and distributed and promoted by Searchlight Pharma, is […]

Kedrion Biopharma and Kamada Announce KEDRAB® (Rabies Immune Globulin [Human]) Now Shipping; Distribution Timed to Meet Spring/Summer Demand for Product

May 9, 2018

FORT LEE, N.J. & REHOVOT, Israel–(BUSINESS WIRE)–Kedrion Biopharma and Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), two leading human-derived protein therapeutics companies, announced today that KEDRAB® [Rabies Immune Globulin (Human)] has been launched in the U.S. and initial shipments are now reaching healthcare practitioners across the country. Deliveries have been timed to meet growing demand for this product […]

New Preventeza™ (Levonorgestrel Tablet, 1.5 mg) Emergency Contraceptive Brought To You by Vagisil® Helps Prevent Pregnancy Before It Starts

May 9, 2018

WHITE PLAINS, N.Y.–(BUSINESS WIRE)–Combe, Inc., the makers of Vagisil®, today announced the launch of Preventeza™ (levonorgestrel tablet, 1.5 mg), an emergency contraceptive (EC) for the prevention of pregnancy. Women have many contraceptive tools available to them; however condoms break and missed pills are inevitable and the rate of unplanned and mistimed pregnancies remains high1. Nearly […]

Medicines360, WCG, and Population Services International Announce Launch of AVIBELA™ Hormonal Intrauterine System in Madagascar

May 8, 2018

SAN FRANCISCO and SAN DIEGO and WASHINGTON, May 7, 2018 /PRNewswire-USNewswire/ — Medicines360, WCG, and Population Services International (PSI) today announced the launch of AVIBELA (levonorgestrel-releasing intrauterine system) 52 mg in Madagascar. This is the first registration and launch of Medicines360’s hormonal intrauterine system (IUS or IUD) in Africa.   AVIBELA’s introduction in Madagascar is […]

Aclaris Therapeutics Announces Availability of ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w)

May 8, 2018

MALVERN, Pa., May 07, 2018 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company, today announced that ESKATA™ is now available for purchase by dermatologists in the United States. ESKATA is the first and only FDA-approved topical treatment for raised seborrheic keratoses (SKs) – benign skin growths that may be a cosmetic concern, […]

Kedrion Biopharma and Kamada Announce KEDRAB® (Rabies Immune Globulin [Human]) Now Shipping; Distribution Timed to Meet Spring/Summer Demand for Product

May 8, 2018

FORT LEE, N.J. and REHOVOT, Israel, May 08, 2018 (GLOBE NEWSWIRE) — Kedrion Biopharma and Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), two leading human-derived protein therapeutics companies, announced today that KEDRAB® [Rabies Immune Globulin (Human)] has been launched in the U.S. and initial shipments are now reaching healthcare practitioners across the country. Deliveries have been timed to […]

Helsinn Group announces the launch of the IV formulation of AKYNZEO® (fosnetupitant/palonosetron) in the United States

May 8, 2018

Lugano, Switzerland, and Iselin, NJ, United States, May 8, 2018 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that the intravenous formulation of AKYNZEO® (a fixed antiemetic combination of fosnetupitant, 235mg, and palonosetron, 0.25mg) for injection has been launched in the United States by its U.S. subsidiary, Helsinn […]

JEOL highlights NMR expertise at ENC 2018

May 8, 2018

JEOL, a leading developer and manufacturer of NMR technology, unveiled new NMR probes and NMR software technologies at the 59th Experimental Nuclear Magnetic Resonance Conference (ENC) in Orlando, Florida. As a major sponsor of this year’s conference, JEOL also hosted a technical seminar that included talks by leading researchers from the Osaka University Institute for […]

Tivic Health Introduces SYNUS Pain Relief™, the First Bioelectronic Device Developed to Relieve Sinus Pain, at The Future of Healthcare Event, May 6-9, in Las Vegas

May 7, 2018

MENLO PARK, Calif.–(BUSINESS WIRE)–Tivic Health Systems Inc™ (“Tivic Health”), a bioelectronic health-tech start-up, introduces SYNUS Pain Relief™, the first bioelectronic healthcare home device developed to offer temporary relief of sinus pain by harnessing the body’s natural electrical system. As a start-up exhibitor at The Future of Healthcare Event May 6-9, Tivic Health is actively reaching […]

FEEDBACK